Efficacy Study of Sargramostim in the Retreatment of Patients Who Have Crohn's Disease Who Have Previously Responded to Treatment With Sargramostim

NCT00206713 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

264

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn Disease

Interventions

DRUG: Sargramostim (Leukine)
DRUG: Placebo

Sponsor

Genzyme, a Sanofi Company